Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 4 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Head & Neck 2Gastrointestinal 2CNS 2Sarcoma 1Genitourinary 1

Conditions

Breast Neoplasms 3Sleep Initiation and Maintenance Disorders 1Pain, Postoperative 1Chronic Pain 1Breast Cancer Female 1

Interventions

Paclitaxel 161Fulvestrant 155Trastuzumab 152pembrolizumab 144Letrozole 136Carboplatin 118pertuzumab 104Cyclophosphamide 102Capecitabine 102Specimen Handling 101Anastrozole 90palbociclib 85abemaciclib 81Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 73trastuzumab deruxtecan 69Radiotherapy 61Biopsy 59Surveys and Questionnaires 56Gemcitabine 52130-nm albumin-bound paclitaxel 52sacituzumab govitecan 50olaparib 50Standard of Care 49Blood Specimen Collection 49Taxes 47Doxorubicin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Dexmedetomidine × Breast × 1 year × Clear all
NCT03063073 2026-02-12

pec's

South Egypt Cancer Institute

Phase 3 Completed
60 enrolled
Breast

Breast Cancer Female

NCT05439005 2026-01-30

OFOBA

Institut Curie

Phase 3 Recruiting
158 enrolled
Breast

Breast Neoplasms

NCT05146778 2025-11-21

RELIEF

Gangnam Severance Hospital

Phase NA Recruiting
230 enrolled
Breast

Breast Neoplasms, Pain, Postoperative, Chronic Pain

NCT05732064 2025-07-31

Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality

Peking University First Hospital

Phase 4 Completed
180 enrolled
Breast

Breast Neoplasms, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡